30 Years of 340B: Policymakers Must Act Now to Prioritize Transparency, Accountability, and Oversight
With the 340B program marking its 30th anniversary in November, we must ask: who is benefiting from this drug pricing […]
340B In The News
AIR340B to FTC: Outsized role of PBMs in safety-net program harms vulnerable patients
For vulnerable patients across America, getting the 340B Drug Pricing Program right could be the difference between receiving lifesaving care
340B hospital charity care levels still abysmal despite growth in safety-net program
With the unparalleled effects of the COVID-19 pandemic, it makes sense that health care is a top concern for Americans.
Washington Needs to Put the Federal 340B Drug Discount Program Under the Microscope
Complex health care regulation is always a work in progress. Consider the Affordable Care Act (ACA), which has helped millions
This safety-net program is failing many vulnerable patients
Many poor Americans, as well as those who lack good insurance, often struggle with the high costs of health care
2021 AIR340B Summit
On Wednesday, May 26, the Alliance for Integrity and Reform of 340B hosted its annual Stakeholder Summit to discuss the
The 340B Program Soared to $38 Billion in 2020—Up 27% vs. 2019
Despite what you may have heard, the 340B Drug Pricing Program continues to thrive.
Biden Budget Offers Potential Oversight Tool on 340B Program
Citizens Against Government Waste (CAGW) has called for reforming the 340B program since 2014. The 340B safety net program was
Summit: 340B an out-of-control train
Originally intended as a way to help provide health care to uninsured and underinsured Americans, the 340B program has mutated
Congress should act on overwhelming support for changes to vital drug discount program
Over the last year, the pandemic has upended our normal lives, exacerbated health inequities, and tested the resiliency of our